INSIGHTS ON DRUG DEVELOPMENT

• Is Lipinski's Rule Of Five Still Relevant In Drug Development?

  Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.

• Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™

  Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.

• Solving Bioavailability Challenges In bRo5 Drugs

  Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.

• White Paper: Spray Drying Biologics: An Alternative To Freeze Drying

  Explore how innovative drying technologies can enhance the stability and efficacy of biologics, ensuring successful outcomes in this rapidly growing sector of the pharmaceutical industry.

• Your AKTA Oligosynt™ System : It's More Than A Machine

  2/9/2026

  Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.

• Spray Dried Biologics For Pulmonary Dosage Forms

  5/15/2026

  Spray drying creates stable inhalable biologic powders with controlled particle size, enabling effective lung delivery, improved stability, and scalable production for respiratory and systemic therapies.

• Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody

  3/24/2025

  Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

• Organ-Chips For Drug Development

  8/2/2024

  Delve into how Organ-on-Chip technology significantly enhances drug development processes and improves the accuracy of clinical translation, leading to more effective and reliable therapeutic outcomes.

• The Role Of A Consulting Firm In The IND Process

  6/10/2025

  Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.